Brookdale Senior Living Appoints Joshua Hausman to Strengthen Board and Enhance Strategy
- Brookdale Senior Living appoints Joshua Hausman as an independent director, effective April 24, 2025.
- Hausman's expertise in healthcare investments aims to enhance Brookdale's occupancy rates and revenue growth.
- The board refresh aligns with Brookdale's commitment to governance and operational efficiency in the senior living industry.
Brookdale Senior Living Strengthens Board with New Appointment
Brookdale Senior Living Inc. announces the appointment of Joshua Hausman as an independent director, effective April 24, 2025. Hausman, who is currently the Managing Partner at MHJ Capital Partners, brings over 20 years of specialized experience in private market investments within the healthcare sector. His background particularly emphasizes skilled nursing and behavioral health facilities, areas critical to Brookdale's mission of providing high-quality senior living services. Denise W. Warren, the Interim CEO and Chairman, expresses confidence that Hausman's extensive expertise will contribute to Brookdale's strategic goals, particularly in enhancing occupancy rates, revenue per available room (RevPAR), and adjusted EBITDA growth. These metrics are vital for the company as it seeks to improve operational performance and create long-term value for shareholders.
The appointment of Hausman follows a broader initiative to refresh the board's composition, highlighted by the recent addition of Mark Fioravanti as an independent director. After the 2025 Annual Meeting, the average tenure of the board will drop to less than four years, a significant shift aimed at increasing agility and responsiveness to market changes. With eight directors, seven of whom are independent, Brookdale demonstrates its commitment to governance practices that align with shareholder interests. This reorganization comes on the heels of Frank M. Bumstead's decision not to seek re-election, underscoring the board’s proactive approach to leadership renewal.
Warren emphasizes the importance of engaging qualified directors who can guide the company in navigating the complexities of the healthcare landscape. In addition to Hausman's appointment, the board is also assessing governance enhancements, particularly regarding director tenure and potential revisions to performance-based long-term incentive awards for executives. These changes reflect Brookdale's focus on aligning executive compensation with long-term strategic objectives, ensuring that the leadership remains accountable to both the company and its shareholders.
In related developments, Brookdale continues to prioritize its operational efficiencies to respond to evolving market demands. The integration of seasoned professionals like Hausman positions the company favorably in an increasingly competitive sector. As Brookdale focuses on enhancing service delivery and operational performance, these strategic board appointments are indicative of a broader commitment to achieving sustainable growth in the senior living industry.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…